Global Cell Line and Membrane Market
Summary:
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
The term “cell line” refers to a culture of cells with an even genetic structure developed from single cells. A cell line is also defined as an indefinitely developed cell culture proliferating indeterminately in an appropriate fresh space and medium. In vitro cell-free systems can replace cell cultures in some fields, but cell lines are still used for diagnostic assays, therapeutic screens and biomedical research. In the 1950s, HeLa, the first human cell line, was created. Cell line development rates have grown over time due to genetic mutation and growth condition adjustment, making the technique more straightforward and more accessible for research labs. Several cell line models are currently available to the scientific community.
Cell lines and membranes find vast applications, including drug discovery and development, basic research, toxicity screening, biopharmaceutical production, drug screening, forensic testing and tissue engineering. Cell lines and membranes have proven highly beneficial across drug discovery applications.
Report Scope
This report provides an overview of the global cell line and membrane market and analyzes market trends. It includes global revenue ($ millions) for base year data 2024, estimated data for 2025 and forecast data from 2026 to 2030. The market is segmented based on product types, subtypes, applications, end users and regions. The regions covered in this study are North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries within these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key players in the global cell line and membrane market. It also has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.
Report Includes
AGC BIOLOGICS
ATCC
CATALENT INC.
CELL BIOLABS INC.
CREATIVE BIOLABS
CROWN BIOSCIENCE
FUJIFILM CELLULAR DYNAMICS INC.
IXCELLS BIOTECHNOLOGIES
KBI BIOPHARMA
LONZA
MILTENYI BIOTEC
PROMEGA CORP.
PROMOCELL GMBH
PROBIOGEN AG
THERMO FISHER SCIENTIFIC INC.
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
The term “cell line” refers to a culture of cells with an even genetic structure developed from single cells. A cell line is also defined as an indefinitely developed cell culture proliferating indeterminately in an appropriate fresh space and medium. In vitro cell-free systems can replace cell cultures in some fields, but cell lines are still used for diagnostic assays, therapeutic screens and biomedical research. In the 1950s, HeLa, the first human cell line, was created. Cell line development rates have grown over time due to genetic mutation and growth condition adjustment, making the technique more straightforward and more accessible for research labs. Several cell line models are currently available to the scientific community.
Cell lines and membranes find vast applications, including drug discovery and development, basic research, toxicity screening, biopharmaceutical production, drug screening, forensic testing and tissue engineering. Cell lines and membranes have proven highly beneficial across drug discovery applications.
Report Scope
This report provides an overview of the global cell line and membrane market and analyzes market trends. It includes global revenue ($ millions) for base year data 2024, estimated data for 2025 and forecast data from 2026 to 2030. The market is segmented based on product types, subtypes, applications, end users and regions. The regions covered in this study are North America, Europe, Asia-Pacific and the Rest of the World (RoW), focusing on major countries within these regions.
The report focuses on the significant driving trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape, which provides the ranking/share of key players in the global cell line and membrane market. It also has a dedicated section of company profiles that covers such details as overview, key financials, product portfolio and recent developments of key market players.
Report Includes
- 54 data tables and 67 additional tables
- An overview of the global market for cell lines and membranes
- An analysis of the global market trends, with market revenue data from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Discussion of the current and future market potential, and quantification of the market by product type, source, end use industry, application, and geographic region
- Identification of applications of cell lines in drug development, diagnostics, and molecular biology
- Description of advances in cell lines for cancer-based therapies
- Details about CAR-T cell and immune check point inhibitor therapy
- Comparison of the manufacturing processes for autologous and allogenic cells
- Explanation of the increasing adoption of cell line technologies in cell-based assay and the surging demand of antibody production
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, and ESG trends of the market
- Analysis of the key companies’ market shares and proprietary technologies, strategic alliances, and patent portfolios
- Company profiles of major players within the industry, including ATCC, Catalent Inc., Lonza, and Thermo Fisher Scientific Inc.
AGC BIOLOGICS
ATCC
CATALENT INC.
CELL BIOLABS INC.
CREATIVE BIOLABS
CROWN BIOSCIENCE
FUJIFILM CELLULAR DYNAMICS INC.
IXCELLS BIOTECHNOLOGIES
KBI BIOPHARMA
LONZA
MILTENYI BIOTEC
PROMEGA CORP.
PROMOCELL GMBH
PROBIOGEN AG
THERMO FISHER SCIENTIFIC INC.
CHAPTER 1 EXECUTIVE SUMMARY
Market Outlook
Scope of Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
CHAPTER 2 MARKET OVERVIEW
Overview and Market Definition
Technology Background
Development of Cell Lines and Cell Culture
Supply Chain Analysis
Procurement of Raw Materials
Manufacturing and Development Process
End Users
Porter’s Five Forces Analysis
Threat of New Entrants: Medium
Bargaining Power of Suppliers: Medium
Bargaining Power of Buyers: Medium
Threat of Substitute: Medium
Industry Rivalry: High
PESTEL Analysis
Political
Economical
Social
Technological
Environmental
Legal
Strategic Recommendations
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Advances in Technologies Accelerating the Scale-Up of Cell Lines
Rising Investments by Pharmaceutical and Biotechnology Companies in Drug Development
Increasing Adoption of Cell Line Technologies in Cell-Based Assays
Growing Demand for Cell Culture-Based Vaccines
Market Restraints
High Cost of Cell Biology Research
Shortage of Skilled Professionals
Market Opportunities
Increasing Number of Approvals for Monoclonal Antibody Types
Expansion of Cell Therapy and Regenerative Medicine
CHAPTER 4 REGULATORY LANDSCAPE
Regulations and Standards in Cell Line and Membrane Market
U.S.
European Union
China
India
Japan
Brazil
CHAPTER 5 EMERGING TECHNOLOGIES AND NEW DEVELOPMENTS
Emerging Technologies
Gene Editing
Automation
High-Throughput Screening
CHAPTER 6 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Market Breakdown by Product
Key Takeaways
Cell Lines
Cell Membrane
Market Breakdown by Source
Key Takeaways
Mammalian Cell Lines
Non-Mammalian Cell Lines
Market Breakdown by Application
Key Takeaways
Basic Research
Biopharmaceutical Production
Drug Discovery
Toxicity Testing
Tissue Engineering
Others
Market Breakdown by End User
Key Takeaways
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Other End Users
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 COMPETITIVE INTELLIGENCE
Key Takeaways
Top Players Ranking, 2024
Strategic Analysis
Agreements, Collaborations and Partnerships
New Product Launches
Mergers and Acquisitions
Expansions
Other Strategic Alliances
CHAPTER 8 SUSTAINABILITY IN THE CELL LINE AND MEMBRANE MARKET: ESG PERSPECTIVE
Sustainability in the Cell Line and Membrane Market
ESG Risk Ratings: Understanding the Data
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks
CHAPTER 9 APPENDIX
Methodology
Abbreviations
References
Company Profiles
AGC BIOLOGICS
ATCC
CATALENT INC.
CELL BIOLABS INC.
CREATIVE BIOLABS
CROWN BIOSCIENCE
FUJIFILM CELLULAR DYNAMICS INC.
IXCELLS BIOTECHNOLOGIES
KBI BIOPHARMA
LONZA
MILTENYI BIOTEC
PROMEGA CORP.
PROMOCELL GMBH
PROBIOGEN AG
THERMO FISHER SCIENTIFIC INC.
Market Outlook
Scope of Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
CHAPTER 2 MARKET OVERVIEW
Overview and Market Definition
Technology Background
Development of Cell Lines and Cell Culture
Supply Chain Analysis
Procurement of Raw Materials
Manufacturing and Development Process
End Users
Porter’s Five Forces Analysis
Threat of New Entrants: Medium
Bargaining Power of Suppliers: Medium
Bargaining Power of Buyers: Medium
Threat of Substitute: Medium
Industry Rivalry: High
PESTEL Analysis
Political
Economical
Social
Technological
Environmental
Legal
Strategic Recommendations
CHAPTER 3 MARKET DYNAMICS
Overview
Market Drivers
Advances in Technologies Accelerating the Scale-Up of Cell Lines
Rising Investments by Pharmaceutical and Biotechnology Companies in Drug Development
Increasing Adoption of Cell Line Technologies in Cell-Based Assays
Growing Demand for Cell Culture-Based Vaccines
Market Restraints
High Cost of Cell Biology Research
Shortage of Skilled Professionals
Market Opportunities
Increasing Number of Approvals for Monoclonal Antibody Types
Expansion of Cell Therapy and Regenerative Medicine
CHAPTER 4 REGULATORY LANDSCAPE
Regulations and Standards in Cell Line and Membrane Market
U.S.
European Union
China
India
Japan
Brazil
CHAPTER 5 EMERGING TECHNOLOGIES AND NEW DEVELOPMENTS
Emerging Technologies
Gene Editing
Automation
High-Throughput Screening
CHAPTER 6 MARKET SEGMENTATION ANALYSIS
Segmentation Breakdown
Market Breakdown by Product
Key Takeaways
Cell Lines
Cell Membrane
Market Breakdown by Source
Key Takeaways
Mammalian Cell Lines
Non-Mammalian Cell Lines
Market Breakdown by Application
Key Takeaways
Basic Research
Biopharmaceutical Production
Drug Discovery
Toxicity Testing
Tissue Engineering
Others
Market Breakdown by End User
Key Takeaways
Biotechnology and Pharmaceutical Companies
Academic and Research Institutes
Other End Users
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 COMPETITIVE INTELLIGENCE
Key Takeaways
Top Players Ranking, 2024
Strategic Analysis
Agreements, Collaborations and Partnerships
New Product Launches
Mergers and Acquisitions
Expansions
Other Strategic Alliances
CHAPTER 8 SUSTAINABILITY IN THE CELL LINE AND MEMBRANE MARKET: ESG PERSPECTIVE
Sustainability in the Cell Line and Membrane Market
ESG Risk Ratings: Understanding the Data
ESG Performance Analysis
Environmental Performance
Social Performance
Governance Performance
Concluding Remarks
CHAPTER 9 APPENDIX
Methodology
Abbreviations
References
Company Profiles
AGC BIOLOGICS
ATCC
CATALENT INC.
CELL BIOLABS INC.
CREATIVE BIOLABS
CROWN BIOSCIENCE
FUJIFILM CELLULAR DYNAMICS INC.
IXCELLS BIOTECHNOLOGIES
KBI BIOPHARMA
LONZA
MILTENYI BIOTEC
PROMEGA CORP.
PROMOCELL GMBH
PROBIOGEN AG
THERMO FISHER SCIENTIFIC INC.
LIST OF TABLES
Summary Table : Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 1 : Key Sources and Description of Biological Contamination of Cell Lines and Membranes
Table 2 : Key Mammalian and Insect Cell Cultures
Table 3 : Animal Cell Lines Used in Research
Table 4 : Cell Lines in the Drug Development Process, by Application
Table 5 : Top 15 Biopharmaceutical Companies, by Research and Development Spending, 2023 and 2024
Table 6 : Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 7 : Global Market for Cell Lines and Membranes, by Product, Through 2030
Table 8 : Global Market for Cell Lines, by Region, Through 2030
Table 9 : NCI-60 Cancer Cell Lines
Table 10 : U.S. Cancer Research Grants, by Cancer Type, as of February 2025
Table 11 : Global Market for Cancer Cell Lines, by Region, Through 2030
Table 12 : Global Market for Immunotherapy Cell Lines, by Region, Through 2030
Table 13 : Global Market for Ion Channel Cell Lines, by Region, Through 2030
Table 14 : Global Market for Cell Signaling Pathway Cell Lines, by Region, Through 2030
Table 15 : Global Market for GPCR Cell Lines, by Region, Through 2030
Table 16 : Global Market for Gene Knockout Cell Lines, by Region, Through 2030
Table 17 : Global Market for Other Cell Lines, by Region, Through 2030
Table 18 : Global Market for Cell Membranes, by Region, Through 2030
Table 19 : Global Market for Cell Lines, by Source, Through 2030
Table 20 : Global Market for Mammalian Cell Lines, by Region, Through 2030
Table 21 : Global Market for Non-Mammalian Cell Lines, by Region, Through 2030
Table 22 : Global Market for Cell Lines and Membranes, by Application, Through 2030
Table 23 : Global Cell Line and Membrane Market for Basic Research, by Region, Through 2030
Table 24 : Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 25 : Comparison of Human Cell Lines with Other Expression Systems in the Production of Therapeutic Proteins
Table 26 : Global Cell Line and Membrane Market for Biopharmaceutical Production, by Region, Through 2030
Table 27 : Global Cell Line and Membrane Market for Drug Discovery, by Region, Through 2030
Table 28 : Global Cell Line and Membrane Market for Toxicity Testing, by Region, Through 2030
Table 29 : Cell Lines Used in Tissue Engineering
Table 30 : Global Cell Line and Membrane Market for Tissue Engineering, by Region, Through 2030
Table 31 : Global Cell Line and Membrane Market for Other Applications, by Region, Through 2030
Table 32 : Global Market for Cell Lines and Membranes, by End User, Through 2030
Table 33 : Cell Lines Used in the Production of Biopharmaceuticals
Table 34 : Global Cell Line and Membrane Market for Biotechnology and Pharmaceutical Companies, by Region, Through 2030
Table 35 : Global Cell Line and Membrane Market for Academic Research and Institutes, by Region, Through 2030
Table 36 : Global Cell Line and Membrane Market for Other End Users, by Region, Through 2030
Table 37 : Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 38 : North American Market for Cell Lines and Membranes, by Product, Through 2030
Table 39 : North American Market for Cell Lines and Membranes, by Type, Through 2030
Table 40 : North American Market for Cell Lines and Membranes, by Source, Through 2030
Table 41 : North American Market for Cell Lines and Membranes, by Application, Through 2030
Table 42 : North American Market for Cell Lines and Membranes, by End User, Through 2030
Table 43 : North American Market for Cell Lines and Membranes, by Country, Through 2030
Table 44 : Estimated Incidence of Cancer Cases in the EU-27, by Country, 2022
Table 45 : E.U. Therapeutic Monoclonal Antibodies Approved or in Review, 2023 and 2024
Table 46 : European Market for Cell Lines and Membranes, by Product, Through 2030
Table 47 : European Market for Cell Lines and Membranes, by Type, Through 2030
Table 48 : European Market for Cell Lines and Membranes, by Source, Through 2030
Table 49 : European Market for Cell Lines and Membranes, by Application, Through 2030
Table 50 : European Market for Cell Lines and Membranes, by End User, Through 2030
Table 51 : European Market for Cell Lines and Membranes, by Country, Through 2030
Table 52 : Asia-Pacific Market for Cell Lines and Membranes, by Product, Through 2030
Table 53 : Asia-Pacific Market for Cell Lines and Membranes, by Type, Through 2030
Table 54 : Asia-Pacific Market for Cell Lines and Membranes, by Source, Through 2030
Table 55 : Asia-Pacific Market for Cell Lines and Membranes, by Application, Through 2030
Table 56 : Asia-Pacific Market for Cell Lines and Membranes, by End User, Through 2030
Table 57 : Asia-Pacific Market for Cell Lines and Membranes, by Country, Through 2030
Table 58 : RoW Market for Cell Lines and Membranes, by Product, Through 2030
Table 59 : RoW Market for Cell Lines and Membranes, by Type, Through 2030
Table 60 : RoW Market for Cell Lines and Membranes, by Source, Through 2030
Table 61 : RoW Market for Cell Lines and Membranes, by Application, Through 2030
Table 62 : RoW Market for Cell Lines and Membranes, by End User, Through 2030
Table 63 : RoW Market for Cell Lines and Membranes, by Sub-Region, Through 2030
Table 64 : Top Players Ranking in the Global Cell Line and Membrane Market, 2024
Table 65 : Agreements, Collaborations and Partnerships in the Cell Line and Membrane Market, 2023-2025
Table 66 : New Product Launches in the Cell Line and Membrane Market, 2023 and 2024
Table 67 : Mergers and Acquisitions in the Cell Line and Membrane Market, 2023-2025
Table 68 : Expansion Strategies in the Cell Line and Membrane Market, 2022?2025
Table 69 : Other Competitive Strategies in the Cell Line and Membrane Market, 2022-2024
Table 70 : Key Focus Areas in ESG Metrics
Table 71 : ESG Rankings for Major Cell Line and Membrane Companies, as of December 2024
Table 72 : ESG: Environmental Overview
Table 73 : ESG: Social Factors Overview
Table 74 : ESG: Governance Overview
Table 75 : Abbreviations Used in this Report
Table 76 : AGC Biologics: Company Snapshot
Table 77 : AGC Biologics: Product Portfolio
Table 78 : AGC Biologics: News/Key Developments, 2023 and 2024
Table 79 : ATCC: Company Snapshot
Table 80 : ATCC: Product Portfolio
Table 81 : ATCC: News/Key Developments, 2023 and 2024
Table 82 : Catalent Inc.: Company Snapshot
Table 83 : Catalent Inc.: Financial Performance, FY 2022 and 2023
Table 84 : Catalent Inc.: Product Portfolio
Table 85 : Catalent Inc.: News/Key Developments, 2024 and 2025
Table 86 : Cell Biolabs Inc.: Company Snapshot
Table 87 : Cell Biolabs Inc.: Product Portfolio
Table 88 : Creative Biolabs: Company Snapshot
Table 89 : Creative Biolabs: Product Portfolio
Table 90 : Creative Biolabs: News/Key Developments, 2025
Table 91 : Crown Bioscience: Company Snapshot
Table 92 : Crown Bioscience: Product Portfolio
Table 93 : Crown Bioscience: News/Key Developments, 2024 and 2025
Table 94 : Fujifilm Cellular Dynamics Inc.: Company Snapshot
Table 95 : Fujifilm Cellular Dynamics Inc.: Product Portfolio
Table 96 : Fujifilm Cellular Dynamics Inc.: News/Key Developments, 2022-2024
Table 97 : iXCells Biotechnologies: Company Snapshot
Table 98 : iXCells Biotechnologies: Product Portfolio
Table 99 : iXCells Biotechnologies: News/Key Developments, 2024
Table 100 : KBI Biopharma: Company Snapshot
Table 101 : KBI Biopharma: Product Portfolio
Table 102 : KBI Biopharma: News/Key Developments, 2022 and 2023
Table 103 : Lonza: Company Snapshot
Table 104 : Lonza: Financial Performance, FY 2023 and 2024
Table 105 : Lonza: Product Portfolio
Table 106 : Lonza: News/Key Developments, 2023
Table 107 : Miltenyi Biotec: Company Snapshot
Table 108 : Miltenyi Biotec: Product Portfolio
Table 109 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 110 : Promega Corp.: Company Snapshot
Table 111 : Promega Corp.: Product Portfolio
Table 112 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 113 : PromoCell GmbH: Company Snapshot
Table 114 : PromoCell GmbH.: Product Portfolio
Table 115 : ProBioGen AG: Company Snapshot
Table 116 : ProBioGen AG: Product Portfolio
Table 117 : ProBioGen AG: News/Key Developments, 2023-2025
Table 118 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 119 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 120 : Thermo Fisher Scientific Inc.: Product Portfolio
Summary Table : Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 1 : Key Sources and Description of Biological Contamination of Cell Lines and Membranes
Table 2 : Key Mammalian and Insect Cell Cultures
Table 3 : Animal Cell Lines Used in Research
Table 4 : Cell Lines in the Drug Development Process, by Application
Table 5 : Top 15 Biopharmaceutical Companies, by Research and Development Spending, 2023 and 2024
Table 6 : Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 7 : Global Market for Cell Lines and Membranes, by Product, Through 2030
Table 8 : Global Market for Cell Lines, by Region, Through 2030
Table 9 : NCI-60 Cancer Cell Lines
Table 10 : U.S. Cancer Research Grants, by Cancer Type, as of February 2025
Table 11 : Global Market for Cancer Cell Lines, by Region, Through 2030
Table 12 : Global Market for Immunotherapy Cell Lines, by Region, Through 2030
Table 13 : Global Market for Ion Channel Cell Lines, by Region, Through 2030
Table 14 : Global Market for Cell Signaling Pathway Cell Lines, by Region, Through 2030
Table 15 : Global Market for GPCR Cell Lines, by Region, Through 2030
Table 16 : Global Market for Gene Knockout Cell Lines, by Region, Through 2030
Table 17 : Global Market for Other Cell Lines, by Region, Through 2030
Table 18 : Global Market for Cell Membranes, by Region, Through 2030
Table 19 : Global Market for Cell Lines, by Source, Through 2030
Table 20 : Global Market for Mammalian Cell Lines, by Region, Through 2030
Table 21 : Global Market for Non-Mammalian Cell Lines, by Region, Through 2030
Table 22 : Global Market for Cell Lines and Membranes, by Application, Through 2030
Table 23 : Global Cell Line and Membrane Market for Basic Research, by Region, Through 2030
Table 24 : Therapeutic Area Distribution of Approved Antibody Drugs, Through October 2023
Table 25 : Comparison of Human Cell Lines with Other Expression Systems in the Production of Therapeutic Proteins
Table 26 : Global Cell Line and Membrane Market for Biopharmaceutical Production, by Region, Through 2030
Table 27 : Global Cell Line and Membrane Market for Drug Discovery, by Region, Through 2030
Table 28 : Global Cell Line and Membrane Market for Toxicity Testing, by Region, Through 2030
Table 29 : Cell Lines Used in Tissue Engineering
Table 30 : Global Cell Line and Membrane Market for Tissue Engineering, by Region, Through 2030
Table 31 : Global Cell Line and Membrane Market for Other Applications, by Region, Through 2030
Table 32 : Global Market for Cell Lines and Membranes, by End User, Through 2030
Table 33 : Cell Lines Used in the Production of Biopharmaceuticals
Table 34 : Global Cell Line and Membrane Market for Biotechnology and Pharmaceutical Companies, by Region, Through 2030
Table 35 : Global Cell Line and Membrane Market for Academic Research and Institutes, by Region, Through 2030
Table 36 : Global Cell Line and Membrane Market for Other End Users, by Region, Through 2030
Table 37 : Global Market for Cell Lines and Membranes, by Region, Through 2030
Table 38 : North American Market for Cell Lines and Membranes, by Product, Through 2030
Table 39 : North American Market for Cell Lines and Membranes, by Type, Through 2030
Table 40 : North American Market for Cell Lines and Membranes, by Source, Through 2030
Table 41 : North American Market for Cell Lines and Membranes, by Application, Through 2030
Table 42 : North American Market for Cell Lines and Membranes, by End User, Through 2030
Table 43 : North American Market for Cell Lines and Membranes, by Country, Through 2030
Table 44 : Estimated Incidence of Cancer Cases in the EU-27, by Country, 2022
Table 45 : E.U. Therapeutic Monoclonal Antibodies Approved or in Review, 2023 and 2024
Table 46 : European Market for Cell Lines and Membranes, by Product, Through 2030
Table 47 : European Market for Cell Lines and Membranes, by Type, Through 2030
Table 48 : European Market for Cell Lines and Membranes, by Source, Through 2030
Table 49 : European Market for Cell Lines and Membranes, by Application, Through 2030
Table 50 : European Market for Cell Lines and Membranes, by End User, Through 2030
Table 51 : European Market for Cell Lines and Membranes, by Country, Through 2030
Table 52 : Asia-Pacific Market for Cell Lines and Membranes, by Product, Through 2030
Table 53 : Asia-Pacific Market for Cell Lines and Membranes, by Type, Through 2030
Table 54 : Asia-Pacific Market for Cell Lines and Membranes, by Source, Through 2030
Table 55 : Asia-Pacific Market for Cell Lines and Membranes, by Application, Through 2030
Table 56 : Asia-Pacific Market for Cell Lines and Membranes, by End User, Through 2030
Table 57 : Asia-Pacific Market for Cell Lines and Membranes, by Country, Through 2030
Table 58 : RoW Market for Cell Lines and Membranes, by Product, Through 2030
Table 59 : RoW Market for Cell Lines and Membranes, by Type, Through 2030
Table 60 : RoW Market for Cell Lines and Membranes, by Source, Through 2030
Table 61 : RoW Market for Cell Lines and Membranes, by Application, Through 2030
Table 62 : RoW Market for Cell Lines and Membranes, by End User, Through 2030
Table 63 : RoW Market for Cell Lines and Membranes, by Sub-Region, Through 2030
Table 64 : Top Players Ranking in the Global Cell Line and Membrane Market, 2024
Table 65 : Agreements, Collaborations and Partnerships in the Cell Line and Membrane Market, 2023-2025
Table 66 : New Product Launches in the Cell Line and Membrane Market, 2023 and 2024
Table 67 : Mergers and Acquisitions in the Cell Line and Membrane Market, 2023-2025
Table 68 : Expansion Strategies in the Cell Line and Membrane Market, 2022?2025
Table 69 : Other Competitive Strategies in the Cell Line and Membrane Market, 2022-2024
Table 70 : Key Focus Areas in ESG Metrics
Table 71 : ESG Rankings for Major Cell Line and Membrane Companies, as of December 2024
Table 72 : ESG: Environmental Overview
Table 73 : ESG: Social Factors Overview
Table 74 : ESG: Governance Overview
Table 75 : Abbreviations Used in this Report
Table 76 : AGC Biologics: Company Snapshot
Table 77 : AGC Biologics: Product Portfolio
Table 78 : AGC Biologics: News/Key Developments, 2023 and 2024
Table 79 : ATCC: Company Snapshot
Table 80 : ATCC: Product Portfolio
Table 81 : ATCC: News/Key Developments, 2023 and 2024
Table 82 : Catalent Inc.: Company Snapshot
Table 83 : Catalent Inc.: Financial Performance, FY 2022 and 2023
Table 84 : Catalent Inc.: Product Portfolio
Table 85 : Catalent Inc.: News/Key Developments, 2024 and 2025
Table 86 : Cell Biolabs Inc.: Company Snapshot
Table 87 : Cell Biolabs Inc.: Product Portfolio
Table 88 : Creative Biolabs: Company Snapshot
Table 89 : Creative Biolabs: Product Portfolio
Table 90 : Creative Biolabs: News/Key Developments, 2025
Table 91 : Crown Bioscience: Company Snapshot
Table 92 : Crown Bioscience: Product Portfolio
Table 93 : Crown Bioscience: News/Key Developments, 2024 and 2025
Table 94 : Fujifilm Cellular Dynamics Inc.: Company Snapshot
Table 95 : Fujifilm Cellular Dynamics Inc.: Product Portfolio
Table 96 : Fujifilm Cellular Dynamics Inc.: News/Key Developments, 2022-2024
Table 97 : iXCells Biotechnologies: Company Snapshot
Table 98 : iXCells Biotechnologies: Product Portfolio
Table 99 : iXCells Biotechnologies: News/Key Developments, 2024
Table 100 : KBI Biopharma: Company Snapshot
Table 101 : KBI Biopharma: Product Portfolio
Table 102 : KBI Biopharma: News/Key Developments, 2022 and 2023
Table 103 : Lonza: Company Snapshot
Table 104 : Lonza: Financial Performance, FY 2023 and 2024
Table 105 : Lonza: Product Portfolio
Table 106 : Lonza: News/Key Developments, 2023
Table 107 : Miltenyi Biotec: Company Snapshot
Table 108 : Miltenyi Biotec: Product Portfolio
Table 109 : Miltenyi Biotec: News/Key Developments, 2023 and 2024
Table 110 : Promega Corp.: Company Snapshot
Table 111 : Promega Corp.: Product Portfolio
Table 112 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 113 : PromoCell GmbH: Company Snapshot
Table 114 : PromoCell GmbH.: Product Portfolio
Table 115 : ProBioGen AG: Company Snapshot
Table 116 : ProBioGen AG: Product Portfolio
Table 117 : ProBioGen AG: News/Key Developments, 2023-2025
Table 118 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 119 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 120 : Thermo Fisher Scientific Inc.: Product Portfolio
LIST OF FIGURES
Summary Figure : Global Cell Line and Membrane Market Shares, by Region, 2024
Figure 1 : Cell Line Selection Characteristics
Figure 2 : Supply Chain of the Cell Line and Membrane Market
Figure 3 : Cell Line Development Flow Chart
Figure 4 : Porter’s Five Forces Analysis: Cell Line and Membrane Market
Figure 5 : PESTEL Analysis: Cell Line and Membrane Market
Figure 6 : Strategic Recommendations: Cell Line and Membrane Market
Figure 7 : Market Dynamics of Cell Line and Membrane
Figure 8 : Emerging Technologies in the Cell Line and Membrane Market
Figure 9 : Global Cell Line and Membrane Market Shares, by Product, 2024
Figure 10 : Global Cell Line Market Shares, by Product, 2024
Figure 11 : Process of Growing Cell Lines and Delivering to Patients
Figure 12 : Production Process of Ion Channel Cell Line
Figure 13 : Cell Signaling Pathway Cell Lines, by Application
Figure 14 : GPCR Cell Line Development Process
Figure 15 : Gene Knockout Cell Line Development Process
Figure 16 : Global Cell Membrane Market Shares, by Region, 2024
Figure 17 : Global Cell Line Market Shares, by Source, 2024
Figure 18 : Global Cell Line and Membrane Market Shares, by Application, 2024
Figure 19 : Cell Line and Membrane in Drug Discovery and Development Process, by Application
Figure 20 : Global Cell Line and Membrane Market Shares, by End User, 2024
Figure 21 : Biopharmaceutical Production Using Mammalian Cells
Figure 22 : Cell Lines and Membranes Application in Academic and Research Institutes
Figure 23 : Global Market Shares of Cell Line and Membrane, by Region, 2024
Figure 24 : North American Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 25 : U.S. Elderly* Population, 2010–2050
Figure 26 : European Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 27 : Asia-Pacific Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 28 : RoW Market Shares of Cell Lines and Membranes, by Sub-Region, 2024
Figure 29 : Catalent Inc.: Revenue Share, by Business Unit, FY 2023
Figure 30 : Catalent Inc.: Revenue Share, by Region/Country, FY 2023
Figure 31 : Lonza: Revenue Share, by Business Unit, FY 2024
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
Summary Figure : Global Cell Line and Membrane Market Shares, by Region, 2024
Figure 1 : Cell Line Selection Characteristics
Figure 2 : Supply Chain of the Cell Line and Membrane Market
Figure 3 : Cell Line Development Flow Chart
Figure 4 : Porter’s Five Forces Analysis: Cell Line and Membrane Market
Figure 5 : PESTEL Analysis: Cell Line and Membrane Market
Figure 6 : Strategic Recommendations: Cell Line and Membrane Market
Figure 7 : Market Dynamics of Cell Line and Membrane
Figure 8 : Emerging Technologies in the Cell Line and Membrane Market
Figure 9 : Global Cell Line and Membrane Market Shares, by Product, 2024
Figure 10 : Global Cell Line Market Shares, by Product, 2024
Figure 11 : Process of Growing Cell Lines and Delivering to Patients
Figure 12 : Production Process of Ion Channel Cell Line
Figure 13 : Cell Signaling Pathway Cell Lines, by Application
Figure 14 : GPCR Cell Line Development Process
Figure 15 : Gene Knockout Cell Line Development Process
Figure 16 : Global Cell Membrane Market Shares, by Region, 2024
Figure 17 : Global Cell Line Market Shares, by Source, 2024
Figure 18 : Global Cell Line and Membrane Market Shares, by Application, 2024
Figure 19 : Cell Line and Membrane in Drug Discovery and Development Process, by Application
Figure 20 : Global Cell Line and Membrane Market Shares, by End User, 2024
Figure 21 : Biopharmaceutical Production Using Mammalian Cells
Figure 22 : Cell Lines and Membranes Application in Academic and Research Institutes
Figure 23 : Global Market Shares of Cell Line and Membrane, by Region, 2024
Figure 24 : North American Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 25 : U.S. Elderly* Population, 2010–2050
Figure 26 : European Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 27 : Asia-Pacific Market Shares of Cell Lines and Membranes, by Country, 2024
Figure 28 : RoW Market Shares of Cell Lines and Membranes, by Sub-Region, 2024
Figure 29 : Catalent Inc.: Revenue Share, by Business Unit, FY 2023
Figure 30 : Catalent Inc.: Revenue Share, by Region/Country, FY 2023
Figure 31 : Lonza: Revenue Share, by Business Unit, FY 2024
Figure 32 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 33 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
